Skip to main content

BENZONATATE

Generic: Benzonatate

Verified·Apr 23, 2026
Manufacturer
Pfizer
NDC
85766-066
RxCUI
283417
Route
ORAL
ICD-10 indication
R05.9

Affordability Check

How much will you actually pay for BENZONATATE?

In 30 seconds, see every legitimate way to afford BENZONATATE — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About BENZONATATE

What is this medication? Benzonatate is a non-narcotic prescription medication used primarily to relieve coughing. It belongs to a class of drugs known as antitussives. Unlike some other cough suppressants that act directly on the brain, benzonatate works by numbing the stretch sensors in the lungs and respiratory passages. This action reduces the cough reflex, making it easier for patients to find relief from persistent, dry coughs caused by the common cold or other lung conditions.

This medication is typically swallowed whole as a liquid-filled capsule. It is important not to chew, crush, or suck on the capsule, as the numbing effect can cause a dangerous loss of feeling in the mouth and throat, potentially leading to choking. While it helps manage symptoms, it does not treat the underlying cause of the cough, such as a viral or bacterial infection. Patients should follow their healthcare provider's instructions carefully when using this drug to ensure safety and effectiveness.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for BENZONATATE. Official source: DailyMed (NLM) · Label effective Oct 14, 2025

Indications and usage
INDICATIONS AND USAGE Benzonatate capsules is indicated for the symptomatic relief of cough.
Dosage and administration
DOSAGE AND ADMINISTRATION Adults and Children over 10 years of age: Usual dose is one 100 mg, 150 mg or 200 mg capsule three times a day as needed for cough. If necessary to control cough, up to 600 mg daily in three divided doses may be given. B enzonatate capsules should be swallowed whole. Benzonatate capsules are not to be broken, chewed, dissolved, cut or crushed.
Contraindications
CONTRAINDICATIONS Hypersensitivity to benzonatate or related compounds.
Warnings
WARNINGS Hypersensitivity Severe hypersensitivity reactions (including bronchospasm, laryngospasm and cardiovascular collapse) have been reported which are possibly related to local anesthesia from sucking or chewing the capsule instead of swallowing it. Severe reactions have required intervention with vasopressor agents and supportive measures. Psychiatric Effects Isolated instances of bizarre behavior, including mental confusion and visual hallucinations, have also been reported in patients taking benzonatate capsules in combination with other prescribed drugs. Accidental Ingestion and Death in Children Keep benzonatate capsules out of reach of children. Accidental ingestion of benzonatate capsules resulting in death has been reported in children below age 10. Signs and symptoms of overdose have been reported within 15-20 minutes and death has been reported within one hour of ingestion. If accidental ingestion occurs, seek medical attention immediately (see OVERDOSAGE).
Adverse reactions
ADVERSE REACTIONS Potential Adverse Reactions to benzonatate capsules may include: Hypersensitivity reactions including bronchospasm, laryngospasm, cardiovascular collapse possibly related to local anesthesia from chewing or sucking the capsule. CNS: sedation; headache; dizziness; mental confusion; visual hallucinations. GI: constipation; nausea; GI upset. Der m atologic: pruritus; skin eruptions. Other: nasal congestion; sensation of burning in the eyes; vague “chilly” sensation; numbness of the chest; hypersensitivity. Deliberate or accidental overdose has resulted in death, particularly in children.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Medicare Part D

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.